Cargando…
Phase I Trial of Intra-arterial Administration of Autologous Bone Marrow-Derived Mesenchymal Stem Cells in Patients with Multiple System Atrophy
BACKGROUND: This study is aimed at investigating the safety and tolerability of the intra-arterial administration of autologous bone marrow-derived mesenchymal stem cells (BM-MSCs) in patients with multiple system atrophy- (MSA-) cerebellar type (MSA-C). METHODS: This was a single-center, open-label...
Autores principales: | Chung, Seok Jong, Lee, Tae Yong, Lee, Yang Hyun, Baik, KyoungWon, Jung, Jin Ho, Yoo, Han Soo, Shim, Chang Jae, Eom, Hyojin, Hong, Ji-Yeon, Kim, Dong Joon, Sohn, Young H., Lee, Phil Hyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548132/ https://www.ncbi.nlm.nih.gov/pubmed/34712335 http://dx.doi.org/10.1155/2021/9886877 |
Ejemplares similares
-
Interaction of CSF α‐synuclein and amyloid beta in cognition and cortical atrophy
por: Lee, Young‐gun, et al.
Publicado: (2021) -
White matter hyperintensities and risk of levodopa‐induced dyskinesia in Parkinson’s disease
por: Chung, Seok Jong, et al.
Publicado: (2020) -
Distinct amyloid-dependent patterns of nigra dopamine depletion in Lewy body diseases
por: Baik, Kyoungwon, et al.
Publicado: (2023) -
Feasibility and Efficacy of Intra‐Arterial Administration of Mesenchymal Stem Cells in an Animal Model of Double Toxin‐Induced Multiple System Atrophy
por: Na Kim, Ha, et al.
Publicado: (2017) -
Bone Marrow-Derived Mesenchymal Stem Cell Therapy as a Candidate Disease-Modifying Strategy in Parkinson's Disease and Multiple System Atrophy
por: Lee, Phil Hyu, et al.
Publicado: (2009)